JohnAinslieThompsonMD

PubMed

• Correction to: Extended duration of treatment using reduced‑frequency dosing of anti‑PD‑1 therapy in patients with advanced melanoma and Merkel cell carcinoma.
  Lisa May Ling Tachiki, Daniel S Hippe, Karly Williams Silva, Evan Thomas Hall, William McCamy, Dane Fritzsche, Andrea Perdue, Julia Majovski, Thomas Pulliam, Daniel A ...> ;Cancer Immunology, Immunotherapy. 2023 Dec 1
• 1 citations
  First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Rα, as a single agent and in combination with spartalizumab in patients with adv...
  Rom Leidner, Kevin Conlon, Douglas G McNeel, Andrea Wang-Gillam, Sumati Gupta, Robert Wesolowski, Monica Chaudhari, Nadia Hassounah, Jong Bong Lee, Lang Ho Lee, Jessic...> ;Journal for Immunotherapy of Cancer. 2023 Oct 1
• 1 citations
  Extended duration of treatment using reduced-frequency dosing of anti-PD-1 therapy in patients with advanced melanoma and Merkel cell carcinoma.
  Lisa May Ling Tachiki, Daniel S Hippe, Karly Williams Silva, Evan Thomas Hall, William McCamy, Dane Fritzsche, Andrea Perdue, Julia Majovski, Thomas Pulliam, Daniel A ...> ;Cancer Immunology, Immunotherapy. 2023 Nov 1
• 2 citations
  Concurrent immune checkpoint inhibition and selective immunosuppressive therapy in patients with immune-related enterocolitis.
  Yousef R Badran, Fangwen Zou, Sienna M Durbin, Barbara E Dutra, Hamzah Abu-Sbeih, Anusha S Thomas, Mehmet Altan, John A Thompson, Wei Qiao, Donna E Leet, Po-Ying Lai, ...> ;Journal for Immunotherapy of Cancer. 2023 Jun 1
• 3 citations
  Phase 1 dose-escalation study of SEA-CD40: a non-fucosylated CD40 agonist, in advanced solid tumors and lymphomas.
  Andrew L Coveler, David C Smith, Tycel Phillips, Brendan D Curti, Sanjay Goel, Amitkumar N Mehta, Timothy M Kuzel, Svetomir N Markovic, Olivier Rixe, David L Bajor, Th...> ;Journal for Immunotherapy of Cancer. 2023 Jun 1
• Sclerosing mesenteritis following immune checkpoint inhibitor therapy.
  Gabriel Sperling, Tom Z Liang, Yang Lu, Dongfeng Tan, Kathryn Bollin, Douglas B Johnson, Joanna-Grace M Manzano, Malek Shatila, Anusha S Thomas, John A Thompson, Hao C...> ;Journal of Cancer Research and Clinical Oncology. 2023 Sep 1
• 8 citations
  A multicenter study assessing survival in patients with metastatic renal cell carcinoma receiving immune checkpoint inhibitor therapy with and without cytoreductive ne...
  Evan E Gross, Mingjia Li, Ming Yin, Delaney Orcutt, Duncan Hussey, Elliot Trott, Sarah K Holt, Erin R Dwyer, Joel Kramer, Kaylee Oliva, John L Gore, George R Schade, D...> ;Urologic Oncology. 2023 Jan 1
• 1 citations
  Characteristics, treatment, and outcome of diverticulitis after immune checkpoint inhibitor treatment in patients with malignancies.
  Austin R Thomas, Mostafa Eyada, Miho Kono, Krishnavathana Varatharajalu, Yang Lu, Guofan Xu, Kavea Panneerselvam, Malek Shatila, Mehmet Altan, Jennifer Wang, John A Th...> ;Journal of Cancer Research and Clinical Oncology. 2023 Jul 1
• 15 citations
  First-in-human study of an OX40 (ivuxolimab) and 4-1BB (utomilumab) agonistic antibody combination in patients with advanced solid tumors.
  Omid Hamid, Alberto A Chiappori, John A Thompson, Toshihiko Doi, Siwen Hu-Lieskovan, Ferry A L M Eskens, Willeke Ros, Adi Diab, Jean-Philippe Spano, Naiyer A Rizvi, Je...> ;Journal for Immunotherapy of Cancer. 2022 Oct 1
• 10 citations
  Combining immune checkpoint inhibition plus tyrosine kinase inhibition as first and subsequent treatments for metastatic renal cell carcinoma.
  Yuanquan Yang, Sarah P Psutka, Anish B Parikh, Mingjia Li, Katharine Collier, Abdul Miah, Sherry V Mori, Megan Hinkley, Scott S Tykodi, Evan Hall, John A Thompson, Min...> ;Cancer Medicine. 2022 Aug 1
• 2 citations
  Associating sleep problems with advanced cancer diagnosis, and immune checkpoint treatment outcomes: a pilot study.
  Arthur Sillah, Ulrike Peters, Nathaniel F Watson, Scott S Tykodi, Evan T Hall, Allison Silverman, Rachel C Malen, John A Thompson, Sylvia M Lee, Shailender Bhatia, Jos...> ;Supportive Care in Cancer. 2022 May 1
• 52 citations
  Neoantigen-specific CD4T cells in human melanoma have diverse differentiation states and correlate with CD8T cell, macrophage, and B cell function.
  Joshua R Veatch, Sylvia M Lee, Carolyn Shasha, Naina Singhi, Julia L Szeto, Ata S Moshiri, Teresa S Kim, Kimberly Smythe, Paul Kong, Matthew Fitzgibbon, Brenda Jeserni...> ;Cancer Cell. 2022 Apr 11
• 1 citations
  Can't handle the itch? Refractory immunotherapy-related transient acantholytic dermatosis: prompt resolution with dupilumab.
  Eva Shelton, Coley Doolittle, Michi M Shinohara, John A Thompson, Ata S Moshiri> ;JAAD Case Reports. 2022 Apr 1
• 24 citations
  Immune Checkpoint Inhibitor Use in Solid Organ Transplant Recipients: A Systematic Review.
  Andrew J Portuguese, Scott S Tykodi, Christopher D Blosser, Ted A Gooley, John A Thompson, Evan T Hall> ;Journal of the National Comprehensive Cancer Network. 2022 Apr 1
• 144 citations
  Management of Immunotherapy-Related Toxicities, Version 1.2022, NCCN Clinical Practice Guidelines in Oncology.
  John A Thompson, Bryan J Schneider, Julie Brahmer, Amaka Achufusi, Philippe Armand, Meghan K Berkenstock, Shailender Bhatia, Lihua E Budde, Saurin Chokshi, Marianne Da...> ;Journal of the National Comprehensive Cancer Network. 2022 Apr 1
• 2 citations
  Acute Sigmoid Sinus Compromise Following Skull Base Procedures: Is a "Laissez-Faire" Approach Best?
  Gregory D. Arnone, Katherine E. Kunigelis, Andrei Gurau, Ian Coulter, John A. Thompson, A. Samy Youssef> ;Journal of Neurological Surgery. Part B, Skull Base. 2021 Dec 1
• 90 citations
  Management of Immune-Related Adverse Events in Patients Treated With Chimeric Antigen Receptor T-Cell Therapy: ASCO Guideline.
  Bianca Santomasso, Loretta J. Nastoupil, Sherry Adkins, Christina Lacchetti, Bryan J. Schneider, Milan J. Anadkat, Michael B. Atkins, Kelly J. Brassil, Jeffrey M. Cate...> ;Journal of Clinical Oncology. 2021 Nov 1
• 454 citations
  Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update.
  Bryan J. Schneider, Jarushka Naidoo, Bianca Santomasso, Christina Lacchetti, Sherry Adkins, Milan J. Anadkat, Michael B. Atkins, Kelly J. Brassil, Jeffrey M. Caterino,...> ;Journal of Clinical Oncology. 2021 Nov 1
• 43 citations
  Efficacy and safety of vedolizumab and infliximab treatment for immune-mediated diarrhea and colitis in patients with cancer: a two-center observational study.
  , , , , , , , , , , , , , , , , > ;Journal for Immunotherapy of Cancer. 2021 Nov 1
• 22 citations
  Phase I study of single agent NIZ985, a recombinant heterodimeric IL-15 agonist, in adult patients with metastatic or unresectable solid tumors
  Kevin C. Conlon, Dionysios C. Watson, Thomas A. Waldmann, Antonio Valentin, Cristina Bergamaschi, Barbara K. Felber, Cody J. Peer, William D. Figg, E. Lake Potter, Mar...> ;Journal for Immunotherapy of Cancer. 2021 Nov 1
• 9 citations
  Basal Ganglia Local Field Potentials as a Potential Biomarker for Sleep Disturbance in Parkinson's Disease.
  Alexander J. Baumgartner, Clete A. Kushida, Michael O. Summers, Drew S. Kern, Aviva Abosch, John A. Thompson> ;Frontiers in Neurology. 2021 Oct 28
• 32 citations
  Intralesional TTI-621, a novel biologic targeting the innate immune checkpoint CD47, in patients with relapsed or refractory mycosis fungoides or Sézary syndrome: a mu...
  Christiane Querfeld, John A. Thompson, Matthew H. Taylor, Jennifer DeSimone, Jasmine Zain, Andrei R. Shustov, Carolyn Johns, Sue Ann McCann, Gloria H. Y. Lin, Penka S....> ;The Lancet. Haematology. 2021 Oct 7
• 31 citations
  A Phase I, Open-Label, Dose-Escalation Study of the OX40 Agonist Ivuxolimab in Patients with Locally Advanced or Metastatic Cancers.
  Adi Diab, Omid Hamid, John A. Thompson, Willeke Ros, Ferry A.L.M. Eskens, Toshihiko Doi, Siwen Hu-Lieskovan, Samuel J. Klempner, Bishu J Ganguly, Catherine Fleener, Xi...> ;Clinical Cancer Research. 2021 Oct 6
• 3 citations
  Investigation of Asleep versus Awake Motor Mapping in Resective Brain Surgery.
  Shawn D'Souza, Mohab Abozeid, John A. Thompson, Teguo Daniel Djoyum, D. Ryan Ormond> ;World Neurosurgery. 2021 Oct 4
• 2 citations
  Eosinophilic fasciitis as a paraneoplastic syndrome in melanoma
  Andrea Rea, Alexis Anderson, Ata S. Moshiri, Kelly G. Paulson, John A. Thompson, Andrea Kalus> ;JAAD Case Reports. 2021 Sep 29
• Join now to see all

Journal Articles

• Phase 1 Trials of Anti-ENPP3 Antibody Drug Conjugates in Advanced Refractory Renal Cell Carcinomas  
  Roberto Pili, John A Thompson, Clinical Cancer Research